In a paper published in the journal Nature, Oregon scientist Shoukhrat Mitalipov and his colleagues used the gene-editing tool CRISPR-Cas9 to fix a defective gene in eggs fertilised with sperm from a hypertrophic cardiomyopathy patient.
Tech correspondent Peter Griffin of the Science Media Centre assesses the potential impact of the research here in New Zealand, and discusses how current laws need overhauling to cater for this powerful new technology.